Latest Diabetes: Type II news

Risk Calculator Predicts Morbidity in T2DM, Obesity

A web-based risk calculator can predict the likelihood of morbidity and mortality for obese patients with type 2 diabetes mellitus, according to a study presented at the annual meeting of the American Society for Metabolic and Bariatric Surgery and The Obesity Society (ObesityWeek), held from Nov. 3 to 7 in Las Vegas.

Risk Tool Can Predict Heart Failure in Patients With Diabetes

A novel machine learning-derived risk score can predict the risk for heart failure among outpatients with type 2 diabetes mellitus, according to a study published online Sept. 13 in Diabetes Care to coincide with the annual meeting of the Heart Failure Society of America, held from Sept. 13 to 16 in Philadelphia.

Dapagliflozin Lowers Risk for Worsening Heart Failure

For patients with heart failure and reduced ejection fraction, dapagliflozin is associated with a lower risk for worsening heart failure or death from cardiovascular causes, regardless of the presence of type 2 diabetes, according a study published online Sept. 19 in the New England Journal of Medicine. The research was published to coincide with the annual meeting of the European Association for the Study of Diabetes, held from Sept. 16 to 20 in Barcelona, Spain.

Linagliptin Noninferior for CV Risk in Early Type 2 Diabetes

Linagliptin is noninferior to glimepiride for adults with relatively early type 2 diabetes and elevated cardiovascular risk, according to a study published online Sept. 19 in the Journal of the American Medical Association to coincide with the annual meeting of the European Association for the Study of Diabetes, held from Sept. 16 to 20 in Barcelona, Spain.